4//SEC Filing
Beddingfield III Frederick 4
Accession 0001140361-17-029590
CIK 0001656328other
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 4:20 PM ET
Size
16.0 KB
Accession
0001140361-17-029590
Insider Transaction Report
Form 4
Beddingfield III Frederick
DirectorPresident & CEO
Transactions
- Conversion
Series A-3 Preferred Stock
2017-08-01−14,076→ 0 total(indirect: See Footnote)→ Common Stock (14,076 underlying) - Conversion
Series A-3 Preferred Stock
2017-08-01−112,614→ 0 total(indirect: See Footnote)→ Common Stock (112,614 underlying) - Conversion
Common Stock
2017-08-01+14,076→ 14,076 total(indirect: See Footnote) - Conversion
Series A-3 Preferred Stock
2017-08-01−14,076→ 0 total(indirect: See Footnote)→ Common Stock (14,076 underlying) - Conversion
Common Stock
2017-08-01+14,076→ 14,076 total(indirect: See Footnote) - Conversion
Common Stock
2017-08-01+112,614→ 112,614 total(indirect: See Footnote)
Holdings
- 553,652
Common Stock
Footnotes (5)
- [F1]The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's initial public offering.
- [F2]The shares are directly held by Beddingfield Children's Trust fbo Catherine Sara Beddingfield.
- [F3]The shares are directly held by Beddingfield Children's Trust fbo Claire Elizabeth Beddingfield.
- [F4]The shares are directly held by the Beddingfield Family Trust.
- [F5]The expiration date is not relevant to the conversion of these securities.
Documents
Issuer
Sienna Biopharmaceuticals, Inc.
CIK 0001656328
Entity typeother
Related Parties
1- filerCIK 0001573074
Filing Metadata
- Form type
- 4
- Filed
- Jul 31, 8:00 PM ET
- Accepted
- Aug 1, 4:20 PM ET
- Size
- 16.0 KB